Your browser doesn't support javascript.
loading
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.
Sharrock, Katherine C; Noori, Teymur; Axelsson, Maria; Buti, Maria; Diaz, Asuncion; Fursa, Olga; Hendrickx, Greet; James, Cary; Klavs, Irena; Korenjak, Marko; Maticic, Mojca; Mozalevskis, Antons; Peters, Lars; Rigoni, Rafaela; Rosinska, Magdalena; Ruutel, Kristi; Schatz, Eberhard; Seyler, Thomas; Veldhuijzen, Irene; Duffell, Erika.
Afiliación
  • Sharrock KC; National AIDS Trust, London, United Kingdom.
  • Noori T; European Centre for Disease Prevention and Control, Solna, Sweden.
  • Axelsson M; Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden.
  • Buti M; Liver Unit, Valle d'Hebron University Hospital, Ciberehd del Insituto Carlos III Barcelona, Barcelona, Spain.
  • Diaz A; Instituto de Salud Carlos III, Madrid, Spain.
  • Fursa O; Centre of Excellence for Health Immunity and Infections Copenhagen, Copenhagen, Denmark.
  • Hendrickx G; Viral Hepatitis Prevention Board, Centre for the Evaluation of Vaccination, Vaccine & Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
  • James C; World Hepatitis Alliance, London, United Kingdom.
  • Klavs I; National Institute of Public Health, Ljubljana, Slovenia.
  • Korenjak M; European Liver Patients' Association, Brussels, Belgium.
  • Maticic M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Mozalevskis A; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Peters L; World Health Organization, Regional Office for Europe, Copenhagen, Denmark.
  • Rigoni R; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Rosinska M; Correlation European Harm Reduction Network, Amsterdam, the Netherlands.
  • Ruutel K; Department of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.
  • Schatz E; National Institute for Health Development, Tallinn, Estonia.
  • Seyler T; Correlation European Harm Reduction Network, Amsterdam, the Netherlands.
  • Veldhuijzen I; European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
  • Duffell E; National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, the Netherlands.
PLOS Glob Public Health ; 2(8): e0000841, 2022.
Article en En | MEDLINE | ID: mdl-36962761
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: PLOS Glob Public Health Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: PLOS Glob Public Health Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos